HuGE Literature Finder
Records 1-2
Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients.
Breast cancer research and treatment 2015 Jul 152 (1): 67-76. Vulsteke Christof, Pfeil Alena M, Maggen Charlotte, Schwenkglenks Matthias, Pettengell Ruth, Szucs Thomas D, Lambrechts Diether, Dieudonné Anne-Sophie, Hatse Sigrid, Neven Patrick, Paridaens Robert, Wildiers Ha |
Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel.
Breast cancer research and treatment 2014 Oct 147 (3): 557-70. Vulsteke C, Pfeil A M, Schwenkglenks M, Pettengell R, Szucs T D, Lambrechts D, Peeters M, van Dam P, Dieudonné A S, Hatse S, Neven P, Paridaens R, Wildiers |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: